Answers are grounded in this paper and cite their sources.
OBJECTIVE: To compare growth and metabolic outcomes during the first four years of life among low-birth-weight infants born moderately preterm, late preterm, and at full term. METHODS: Cohort of singleton infants without malformations or congenital infections, weighing 1500-2499 g, followed in an outpatient clinic during the first four years of life, from 2014 to 2019. Three groups were compared: G1 (moderate preterm, n = 76), G2 (late preterm, n = 107), and G3 (term, n = 98). Weight, length, and head circumference were assessed using Z-scores. Metabolic assessment (cholesterol, triglycerides, fasting blood glucose) was performed once a year from the 2nd year onwards. Outcomes included growth failure, overweight/obesity risk, dyslipidemia, and glucose disorders. Group comparisons used ANOVA, Chi-square test, and repeated-measures ANOVA. RESULTS: Growth Z-scores remained within normal limits but differed among groups, as moderate preterm infants maintained consistently higher Z-scores through the third year of life. Weight growth failure was more frequent in late preterm and term infants, with term infants showing a higher prevalence of thinness at 36-48 months and moderate preterm infants showing a higher risk of overweight at 24 months. No intergroup differences were found in lipid profiles, although triglycerides remained above recommended levels across all groups and time points, and preterm infants showed elevated total cholesterol at 4 years. CONCLUSION: Growth patterns differed across groups in the first 4 years, with moderate preterm showing catch-up and higher Z-scores, while late preterm and term infants had more weight growth failure. Lipid profile abnormalities were observed in all groups from the second year of life onward.
No takes yet. Share an insight, caveat, or question.
Kiy et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: